Renowned Experts Join Forces to Build a Global Brand in Heavy Ion Therapy

Recently, The Gansu Wuwei Cancer Hospital has welcomed the official addition of three prominent figures in the field of radiotherapy: Chief Physician Ma Changying, Chief Physician Qiao Hongmei, and Dr. Liao Anyan. This move signifies a solid step forward for The Gansu Wuwei Cancer Hospital in advancing its heavy ion clinical treatment capabilities on a global scale, laying a robust foundation for establishing a worldwide brand in heavy ion therapy.

Chief Physician Ma Changying stands out in the field of radiotherapy for head and neck tumors, with years of clinical experience that have amassed a treasure trove of invaluable insights. Her profound expertise in radiotherapy and comprehensive treatment for systemic malignant tumors enables him to devise precise strategies for complex cases such as head and neck tumors, lung cancer, and gynecological malignancies. With her unique perspectives and innovative treatment plans, she has consistently brought light to patients battling these formidable diseases. Her joining is set to introduce cutting-edge radiotherapy technologies and pioneering concepts to the hospital, infusing new vitality into the diagnosis and treatment of malignant tumors.

Chief Physician Qiao Hongmei is also widely renowned, earning high acclaim in the industry for her exceptional mastery in the diagnosis and treatment of various types of tumors. Whether dealing with common tumors or complex multiple tumors, from precise diagnosis to concurrent chemoradiotherapy and molecular targeted therapy, Dr. Qiao handles each case with remarkable proficiency. She is highly skilled in advanced radiotherapy techniques such as intensity-modulated radiation therapy (IMRT) and brachytherapy. Her addition serves as a crucial piece in the hospital's comprehensive cancer treatment system, significantly enhancing the institution's overall capability to tackle the challenges of oncology.

Dr. Liao Anyan has dedicated herself to pioneering research in the radiotherapy of abdominal and pelvic tumors, achieving remarkable results. With profound insights into radiotherapy and comprehensive treatment for various solid tumors, she has particularly focused on abdominal and pelvic malignancies such as liver cancer, rectal cancer, and prostate cancer. Her extensive practical experience and pioneering exploration of precision radiotherapy techniques have led to outstanding achievements in the application of advanced technologies like intensity-modulated radiation therapy (IMRT), Gamma Knife, and CyberKnife. Dr. Liao's arrival will undoubtedly propel the hospital to new heights in the realm of precision radiotherapy.

As the only hospital in the world operating two heavy ion tumor treatment systems simultaneously, The Gansu Wuwei Cancer Hospital boasts a profound foundation. Supported by industry luminaries such as Professor Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiation Oncology at Peking University Health Science Center; Professor Wang Junjie, Chairman of the Radiotherapy Committee of the Chinese Medical Association and Director of the Lanzhou Branch of the hospital; Professor Ren Yimin, former Chairman of the Taiwan Society of Therapeutic Radiology and Oncology; and Professor Wu Jiaming, former Chief Physicist at Chang Gung Memorial Hospital in Taiwan, the hospital has established a comprehensive, full-lifecycle oncology treatment ecosystem. This is further enhanced by cutting-edge medical equipment, including China's first and second heavy ion treatment systems, the domestically developed Toumai Four-Arm Surgical Robot, and the Discovery 710 PET-CT.

With the recent addition of the three distinguished experts, the hospital's radiotherapy team has been infused with fresh vitality, further elevating its professional capabilities and solidifying its leadership in the field of heavy ion therapy. This marks a significant leap forward in the hospital's pursuit of excellence in cancer treatment.

Looking ahead, Gansu Wuwei Cancer Hospital will remain steadfast in its commitment to the original aspiration of "unwavering focus and healing the wounded and rescuing the dying." The hospital will continue to delve deeply into the innovation of medical technologies and optimize service quality, bringing the light of hope to cancer patients. With unwavering determination, the hospital will strengthen discipline construction and cultivate professional talents, striving to become a global leader in heavy ion therapy. It aims to contribute significantly to the grand vision of Healthy China, using excellent medical skills and sincere benevolence to write a new chapter in cancer treatment.